🇺🇸 FDA

Intelligence · Patent portfolio

SANGAMO THERAPEUTICS Patents

Full USPTO pharma patent portfolio for SANGAMO THERAPEUTICS — grant dates, expiration, and drug cross-links.

Patents
192
Expiring ≤24m
7

Quick answer

SANGAMO THERAPEUTICS has 192 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 7 expire within 24 months — use filters for patent-cliff planning.

Page 4 of 4

  1. US 8956828

    Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8912138

    DNA-binding proteins and uses thereof

    Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8871905

    Modification of CXCR4 using engineered zinc finger proteins

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8841260

    Methods and compositions for treating Huntington's Disease

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8822221

    Targeted integration into the PPP1R12C locus

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8772453

    Compositions for linking zinc finger modules

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8771985

    Genome editing of a Rosa locus using zinc-finger nucleases

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8735153

    Modulation of stem cells using zinc finger proteins

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8703489

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8680021

    Zinc finger proteins for DNA binding and gene regulation in plants

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8586526

    DNA-binding proteins and uses thereof

    Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8569253

    Methods and compositions for gene inactivation

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8563314

    Methods and compositions for modulating PD1

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8551945

    Methods and compositions for treating neuropathies

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8524500

    Methods and compositions for targeted cleavage and recombination

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8524221

    Methods and compositions for gene inactivation

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8466267

    Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene

    Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8349810

    Methods for targeted cleavage and recombination of CCR5

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8313925

    Zinc finger proteins and method for inactivating a dhfr gene in a chinese hamster ovary cell

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8268618

    Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8110379

    Targeted integration into the PPP1R12C locus

    Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8071564

    Regulation of angiogenesis with zinc finger proteins

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8012946

    Anti-angiogenic methods and compositions

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7985887

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7972854

    Methods and compositions for targeted cleavage and recombination

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7951925

    Methods and compositions for gene inactivation

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7893022

    Anti-angiogenic methods and compositions

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7888121

    Methods and compositions for targeted cleavage and recombination

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7795209

    Anti-angiogenic methods and compositions

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7732196

    Anti-angiogenic methods and compositions

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7705139

    Zinc finger proteins for DNA binding and gene regulation in plants

    Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7605140

    Regulation of angiogenesis with zinc finger proteins

    Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7560440

    Regulation of angiogenesis with zinc finger proteins

    Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7534775

    Methods and compositions for modulating cardiac contractility

    Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7358085

    Anti-angiogenic methods and compositions

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7273923

    Zinc finger proteins for DNA binding and gene regulation in plants

    Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7253273

    Treatment of neuropathic pain with zinc finger proteins

    Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7220719

    Modulation of endogenous gene expression in cells

    Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7163824

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7070934

    Ligand-controlled regulation of endogenous gene expression

    Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7067317

    Regulation of angiogenesis with zinc finger proteins

    Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7026462

    Regulation of angiogenesis with zinc finger proteins

    Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 7013219

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Expires Mon Mar 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6979539

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6933113

    Modulation of endogenous gene expression in cells

    Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6824978

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6607882

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6534261

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Expires Mon Mar 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does SANGAMO THERAPEUTICS have?

192 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do SANGAMO THERAPEUTICS patents expire?

7 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.